Literature DB >> 3066569

Primary lymphocutaneous Nocardia brasiliensis infection: three case reports and a review of the literature.

J G Schwartz1, D A McGough, R E Thorner, R J Fetchick, F O Tio, M G Rinaldi.   

Abstract

The occurrence of human nocardiosis is increasing in both immunocompetent as well as immunosuppressed patients. We report three rare cases of primary lymphocutaneous Nocardia brasiliensis infection. The mode of inoculation in each case was that of a puncture wound that occurred 1-3 wk prior to the development of the clinically apparent infections. The original clinical diagnosis was erroneous in each case. A review of 16 previously reported cases is presented as well as a discussion of appropriate medical therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3066569     DOI: 10.1016/0732-8893(88)90049-1

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

1.  Enzymatic characterization of Nocardia spp. and related bacteria by API ZYM profile.

Authors:  P Boiron; F Provost
Journal:  Mycopathologia       Date:  1990-04       Impact factor: 2.574

Review 2.  Nocardia species: host-parasite relationships.

Authors:  B L Beaman; L Beaman
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 3.  Primary Lymphocutaneous Nocardia brasiliensis in an Immunocompetent Host: Case Report and Literature Review.

Authors:  Igor Dumic; Alethea Brown; Kyle Magee; Sammer Elwasila; Marija Kaljevic; Marina Antic; Oladapo Igandan; Milena Cardozo; Libardo Rueda Prada; Margaret Paulson
Journal:  Medicina (Kaunas)       Date:  2022-03-28       Impact factor: 2.948

4.  Sporotrichoid Skin Infection Caused by Nocardia brasiliensis in a Kidney Transplant Patient.

Authors:  Folusakin Ayoade; Pradeep Mada; Andrew Stevenson Joel Chandranesan; Mohammed Alam
Journal:  Diseases       Date:  2018-07-25

Review 5.  Isolated Nocardiosis, an Unrecognized Primary Immunodeficiency?

Authors:  Rubén Martínez-Barricarte
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.